IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False?

Inflammatory bowel diseases (IBDs) are chronic disorders of the gastrointestinal tract. The goal of IBD treatment is to reduce the inflammation period and induce long-term remission. Use of anti-inflammatory drugs including corticosteroids, immunosuppressants and biologicals, is often the first step...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghavami, Shaghayegh Baradaran, Shahrokh, Shabnam, Hossein-Khannazer, Nikoo, Shpichka, Anastasia, Asadzadeh Aghdaei, Hamid, Timashev, Peter, Vosough, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481906/
https://www.ncbi.nlm.nih.gov/pubmed/32779446
http://dx.doi.org/10.22074/cellj.2020.7603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481906/
https://www.ncbi.nlm.nih.gov/pubmed/32779446
http://dx.doi.org/10.22074/cellj.2020.7603

Ejemplares similares